Downregulation of PA28α induces proteasome remodeling and results in resistance to proteasome inhibitors in multiple myeloma

por Gu, Yanyan, Barwick, Benjamin G., Shanmugam, Mala, Hofmeister, Craig C., Kaufman, Jonathan, Nooka, Ajay, Gupta, Vikas, Dhodapkar, Madhav, Boise, Lawrence H., Lonial, Sagar
Publicado 2020

Eliminating the monitoring period with subcutaneous daratumumab: a single-center experience

por Maples, Kathryn T., Hall, Kevin H., Joseph, Nisha S., Hofmeister, Craig C., Gupta, Vikas, Dhodapkar, Madhav V., Kaufman, Jonathan L., Nooka, Ajay K., Lonial, Sagar
Publicado 2023

The Hematopoietic Stem Cell Transplant Comorbidity Index (HCT-CI) Can Predict for 30-Day Readmission Following Autologous Stem Cell Transplant for Lymphoma and Multiple Myeloma

por Jaglowski, Samantha M., Ruppert, Amy S., Hofmeister, Craig C., Elder, Patrick, Blum, William, Klisovic, Rebecca, Vasu, Sumithira, Penza, Sam, Efebera, Yvonne A, Benson, Don M., Devine, Steven M., Andritsos, Leslie A
Publicado 2014

PARP1 and POLD2 as prognostic biomarkers for multiple myeloma in autologous stem cell transplant

por Thomas, Melissa, Li, Junan, King, Kevan, Persaud, Avinash K., Duah, Ernest, Vangundy, Zachary, Hofmeister, Craig C., Lamba, Jatinder K., Tan, Aik Choon, Fridley, Brooke L., Poi, Ming J., Seligson, Nathan D.
Publicado 2023

CS1-Specific Chimeric Antigen Receptor (CAR)-Engineered Natural Killer Cells Enhance In Vitro and In Vivo Anti-tumor Activity Against Human Multiple Myeloma

por Chu, Jianhong, Deng, Youcai, Benson, Don M., He, Shun, Hughes, Tiffany, Zhang, Jianying, Peng, Yong, Mao, Hsiaoyin, Yi, Ling, Ghoshal, Kalpana, He, Xiaoming, Devine, Steven M., Zhang, Xiaoliu, Caligiuri, Michael A., Hofmeister, Craig C., Yu, Jianhua
Publicado 2013

Pharmacokinetic‐Pharmacodynamic Model of Neutropenia in Patients With Myeloma Receiving High‐Dose Melphalan for Autologous Stem Cell Transplant

por Cho, Yu Kyoung, Irby, Donald J., Li, Junan, Sborov, Douglas W., Mould, Diane R., Badawi, Mohamed, Dauki, Anees, Lamprecht, Misty, Rosko, Ashley E., Fernandez, Soledad, Hade, Erinn M., Hofmeister, Craig C., Poi, Ming, Phelps, Mitch A.
Publicado 2018

Divergence of variant binding/neutralizing antibodies following SARS-CoV-2 booster vaccines in myeloma: Impact of hybrid immunity

por Moreno, Alberto, Manning, Kelly, Azeem, Maryam I., Nooka, Ajay K., Ellis, Madison, Manalo, Renee Julia, Switchenko, Jeffrey M., Wali, Bushra, Kaufman, Jonathan L., Hofmeister, Craig C., Joseph, Nisha S., Lonial, Sagar, Dhodapkar, Kavita M., Dhodapkar, Madhav V., Suthar, Mehul S.
Publicado 2023

Multiple myeloma immunoglobulin lambda translocations portend poor prognosis

por Barwick, Benjamin G., Neri, Paola, Bahlis, Nizar J., Nooka, Ajay K., Dhodapkar, Madhav V., Jaye, David L., Hofmeister, Craig C., Kaufman, Jonathan L., Gupta, Vikas A., Auclair, Daniel, Keats, Jonathan J., Lonial, Sagar, Vertino, Paula M., Boise, Lawrence H.
Publicado 2019

Correction: HDAC inhibitor AR-42 decreases CD44 expression and sensitizes myeloma cells to lenalidomide

por Canella, Alessandro, Nieves, Hector Cordero, Sborov, Douglas W., Cascione, Luciano, Radomska, Hanna S., Smith, Emily, Stiff, Andrew, Consiglio, Jessica, Caserta, Enrico, Rizzotto, Lara, Zanesi, Nicola, Stefano, Volinia, Kaur, Balveen, Mo, Xiaokui, Byrd, John C., Efebera, Yvonne A., Hofmeister, Craig C., Pichiorri, Flavia
Publicado 2023

HDAC inhibitor AR-42 decreases CD44 expression and sensitizes myeloma cells to lenalidomide

por Canella, Alessandro, Nieves, Hector Cordero, Sborov, Douglas W., Cascione, Luciano, Radomska, Hanna S., Smith, Emily, Stiff, Andrew, Consiglio, Jessica, Caserta, Enrico, Rizzotto, Lara, Zanesi, Nicola, Stefano, Volinia, Kaur, Balveen, Mo, Xiaokui, Byrd, John C., Efebera, Yvonne A., Hofmeister, Craig C., Pichiorri, Flavia
Publicado 2015

Gain of Chromosome 1q is associated with early progression in multiple myeloma patients treated with lenalidomide, bortezomib, and dexamethasone

por Schmidt, Timothy M., Barwick, Benjamin G., Joseph, Nisha, Heffner, Leonard T., Hofmeister, Craig C., Bernal, Leon, Dhodapkar, Madhav V., Gupta, Vikas A., Jaye, David L., Wu, Jiayi, Goyal, Subir, Chen, Zhengjia, Boise, Lawrence H., Lonial, Sagar, Nooka, Ajay K., Kaufman, Jonathan L.
Publicado 2019

Early phase clinical studies of AR‐42, a histone deacetylase inhibitor, for neurofibromatosis type 2‐associated vestibular schwannomas and meningiomas

por Welling, D. Bradley, Collier, Katharine A., Burns, Sarah S., Oblinger, Janet L., Shu, Edina, Miles‐Markley, Beth A., Hofmeister, Craig C., Makary, Mina S., Slone, H. Wayne, Blakeley, Jaishri O., Mansouri, S. Alireza, Neff, Brian A., Jackler, Robert K., Mortazavi, Amir, Chang, Long‐Sheng
Publicado 2021

Twice‐weekly ixazomib in combination with lenalidomide‐dexamethasone in patients with newly diagnosed multiple myeloma

por Richardson, Paul G., Hofmeister, Craig C., Rosenbaum, Cara A., Htut, Myo, Vesole, David H., Berdeja, Jesus G., Liedtke, Michaela, Chari, Ajai, Smith, Stephen D., Lebovic, Daniel, Raje, Noopur, Byrne, Catriona, Liao, Eileen, Gupta, Neeraj, Bacco, Alessandra Di, Estevam, Jose, Berg, Deborah, Baz, Rachid
Publicado 2018

Venetoclax sensitivity in multiple myeloma is associated with B-cell gene expression

por Gupta, Vikas A., Barwick, Benjamin G., Matulis, Shannon M., Shirasaki, Ryosuke, Jaye, David L., Keats, Jonathan J., Oberlton, Benjamin, Joseph, Nisha S., Hofmeister, Craig C., Heffner, Leonard T., Dhodapkar, Madhav V., Nooka, Ajay K., Lonial, Sagar, Mitsiades, Constantine S., Kaufman, Jonathan L., Boise, Lawrence H.
Publicado 2021

Oncolytic herpes simplex virus infects myeloma cells in vitro and in vivo

por Ghose, Jayeeta, Dona, Ada, Murtadha, Mariam, Gunes, Emine Gulsen, Caserta, Enrico, Yoo, Ji Young, Russell, Luke, Jaime-Ramirez, Alena Cristina, Barwick, Benjamin G., Gupta, Vikas A., Sanchez, James F., Sborov, Douglas W., Rosen, Steven T., Krishnan, Amrita, Boise, Lawrence H., Kaur, Balveen, Hofmeister, Craig C., Pichiorri, Flavia
Publicado 2021

Venetoclax ex vivo functional profiling predicts improved progression-free survival

por Gupta, Vikas A., Matulis, Shannon M., Barwick, Benjamin G., Bog, R. Devin, Shebelut, Conrad W., Shanmugam, Mala, Neri, Paola, Bahlis, Nizar J., Dhodapkar, Madhav V., Heffner, Leonard T., Hofmeister, Craig C., Joseph, Nisha S., Lonial, Sagar, Kaufman, Jonathan L., Jaye, David L., Nooka, Ajay K., Boise, Lawrence H.
Publicado 2022

In vivo NCL targeting affects breast cancer aggressiveness through miRNA regulation

por Pichiorri, Flavia, Palmieri, Dario, De Luca, Luciana, Consiglio, Jessica, You, Jia, Rocci, Alberto, Talabere, Tiffany, Piovan, Claudia, Lagana, Alessandro, Cascione, Luciano, Guan, Jingwen, Gasparini, Pierluigi, Balatti, Veronica, Nuovo, Gerard, Coppola, Vincenzo, Hofmeister, Craig C., Marcucci, Guido, Byrd, John C., Volinia, Stefano, Shapiro, Charles L., Freitas, Michael A., Croce, Carlo M.
Publicado 2013

Correction: In vivo NCL targeting affects breast cancer aggressiveness through miRNA regulation

por Pichiorri, Flavia, Palmieri, Dario, De Luca, Luciana, Consiglio, Jessica, You, Jia, Rocci, Alberto, Talabere, Tiffany, Piovan, Claudia, Lagana, Alessandro, Cascione, Luciano, Guan, Jingwen, Gasparini, Pierluigi, Balatti, Veronica, Nuovo, Gerard, Coppola, Vincenzo, Hofmeister, Craig C., Marcucci, Guido, Byrd, John C., Volinia, Stefano, Shapiro, Charles L., Freitas, Michael A., Croce, Carlo M.
Publicado 2017

Determinants of Neutralizing Antibody Response After SARS CoV-2 Vaccination in Patients With Myeloma

por Nooka, Ajay K., Shanmugasundaram, Uma, Cheedarla, Narayana, Verkerke, Hans, Edara, Venkata V., Valanparambil, Rajesh, Kaufman, Jonathan L., Hofmeister, Craig C., Joseph, Nisha S., Lonial, Sagar, Azeem, Maryam, Manalo, Julia, Switchenko, Jeffrey M., Chang, Andres, Linderman, Susanne L., Roback, John D., Dhodapkar, Kavita M., Ahmed, Rafi, Suthar, Mehul S., Neish, Andrew S., Dhodapkar, Madhav V.
Publicado 2022

Daratumumab monotherapy for patients with intermediate-risk or high-risk smoldering multiple myeloma: a randomized, open-label, multicenter, phase 2 study (CENTAURUS)

por Landgren, C. Ola, Chari, Ajai, Cohen, Yael C., Spencer, Andrew, Voorhees, Peter, Estell, Jane A., Sandhu, Irwindeep, Jenner, Matthew W., Williams, Catherine, Cavo, Michele, van de Donk, Niels W. C. J., Beksac, Meral, Moreau, Philippe, Goldschmidt, Hartmut, Kuppens, Steven, Bandekar, Rajesh, Clemens, Pamela L., Neff, Tobias, Heuck, Christoph, Qi, Ming, Hofmeister, Craig C.
Publicado 2020